The Health Protection Agency (HPA) has announced that it is taking significant measures to assess the potential spread of Mpox (monkeypox) in the Maldives, develop strategies to control the disease, and prepare for testing and treatment. Mpox is an infectious disease caused by the monkeypox virus, which can lead to a painful rash, swollen lymph nodes, and fever.
The World Health Organisation (WHO) declared the Mpox outbreak a global emergency on August 14, citing a surge in cases in Congo, across several African countries, and beyond. This upsurge has been classified as a Public Health Emergency of International Concern (PHEIC) under the International Health Regulations (2005) (IHR). Since the outbreak began in 2022, a total of 99,000 cases have been reported in 116 countries.
In response to the outbreak, HPA has been closely monitoring the situation and taking proactive steps to prevent the spread of Mpox in the Maldives. The agency is currently evaluating the risk of Mpox transmission within the country, developing strategies to control its spread, and preparing to conduct tests and provide treatment if necessary. Additionally, HPA is working to increase awareness among healthcare workers and strengthen disease surveillance.
Mpox, while currently known to be sexually transmissible, can also spread through the exchange of bodily fluids and respiratory droplets from an infected individual. It can be contracted by sharing everyday items like bedsheets, towels, and clothing with an infected person. Furthermore, the virus can be transmitted through contact with infected animals, such as during hunting, skinning, or cooking. Common symptoms include fever, body aches, fatigue, swollen lymph nodes, and rashes.
Although most individuals recover from Mpox without medical intervention, severe cases requiring hospitalization have been reported. While there are no specific treatments for Mpox, supportive care can help manage symptoms and aid in recovery.